Abrdn PLC Dyne Therapeutics, Inc. Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Abrdn PLC holds 25,803 shares of DYN stock, worth $347,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,803Holding current value
$347,308% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
209Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$108 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$99.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$92.4 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$91.8 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$91.7 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $697M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...